Wanne ya fi kyau, Actovegin ko Cerebrolysin?

A kan kasuwar magunguna ta Rasha, Actovegin da Cerebrolysin suna cikin wakilai waɗanda ke haɓaka kwararar jini da haɓakawa a cikin tasoshin kwakwalwa. Wadannan kwayoyi suna ƙoƙarin yin maganin senile dementia da cutar Alzheimer. An tsara su ne bayan bugun jini da raunin kwakwalwa - a cikin lokacin tsananin kuma a matakin farfadowa. Kamfanoni magunguna sun ce: Actovegin da Cerebrolysin suna daidaita aikin jijiyoyi, inganta hankali da ƙwaƙwalwa, da haɓaka murmurewa. Masana kimiyya da masu aikin likita sunyi shakku: babu bayanai game da tasiri na kwayoyi. Wanene yakamata yayi imani da yadda ake tantance shi?

Kwararrun majiyar mu sunyi nazarin sakamakon Actovegin da Cerebrolysin a jikin ɗan adam. Mun gano cewa duka magungunan suna cikin kwayoyi tare da tasiri marasa inganci, kuma ba daidai bane a gwada tasirin su. Yawancin masana ilimin kimiyya suna cewa muna ma'amala da placebo. Kuma idan magungunan biyu dumushe ne, ga mai haƙuri babu bambanci a tsakanin su.

Bari mu bincika abubuwan da aka sanya magunguna don inganta hawan jini, dalilin da yasa aka tsara su, da wane tasiri ya kamata a tsammani daga gare su.

Halayen Actovegin

Actovegin sigar analog (jigo) ne na cerebrolysin. An karɓa daga jinin 'yan maruƙa da aka tsarkake daga furotin da wasu sel (ta hanyar zubar da jini). Yana kammala sel da lalatattun abubuwa tare da ƙoshin jiki tare da glucose da oxygen. Akwai shi a cikin nau'ikan allunan da kuma mafita don maganin baka da allura.

The kamance na hadaddun abubuwa

Peptides, manyan abubuwa masu aiki, suna sa waɗannan kwayoyi su yi kama. Babban tasirin su akan jikin mai haƙuri shima bashi da bambance-bambance:

• maido da aikin kwakwalwa,
• tsari na jini zuwa kwakwalwa,
• babban inganci a cikin raunin jijiyoyin jiki.

Wasu likitocin sun ba da shawarar shan Actovegin da Cerebrolysin a lokaci guda, tunda suna haɗuwa da haɓaka kayan haɓaka magungunan junan su.

Amma cerebrolysin da actovegin, waɗanda masu haƙuri da yawa suna kwatanta, suna da bambance-bambance da yawa.

Bambanci tsakanin cerebrolysin da actovegin

Babban bambanci tsakanin magungunan shine kasancewar yawancin contraindications a cikin cerebrolysin da ƙananan adadin su a cikin actovegin.

Actovegin galibi ana wajabta shi ga yara, har ma da jarirai. Ba a ba da shawarar Cerebrolysin a lokacin ƙuruciya ba.

Bambanci da kamanceceniya suna da actovegin da cerebrolysin, amma likitan da ke halartar ya kamata ya fahimce su.

Magungunan jini: menene aka yi dasu?

Mun bincika umarnin don amfani da kwayoyi kuma mun gano abin da ya haɗu da abun da ke ciki:

Actovegin da aka samu daga jinin haila daga zubar da jinin marayu. Akwai shi a allunan da allura. Tabletaya daga cikin kwamfutar hannu ya ƙunshi 200 mcg na kayan aiki mai aiki. An gabatar da ampoules a cikin 2, 5 da 10 ml (80, 200 da 400 mg, bi da bi).

Cerebrolysin hadaddun sunadarai ne da aka samo daga kwakwalwar aladu. Akwai a matsayin allura. A cikin ampoule daya - 215 MG.

Kudin magunguna daban. 5 ampoules na bayani (5 ml kowane) na Cerebrolysin zai biya 1000-1200 rubles. Hakanan adadin Actovegin yana biyan 500-600 rubles. Babban farashin Cerebrolysin ba yana nufin cewa ya jimre da aikinsa da kyau ba - kuma yanzu zaku iya tabbata da shi.

Likitoci suna bita

Vasily Gennadievich, ɗan shekara 48, St. Petersburg.

Ina rubanya cerebrolysin don inganta aikin fahimi. Magungunan yana da tasiri har tsawon watanni 5-8. Wani lokaci, saboda tsadar girma na cerebrolysin, Na maye gurbinsa da analog, Actovegin.

Ban ci karo da rashin lafiyan halayen ga cerebrolysin a aikace.

Anna Vasilievna, 53 years, Volgograd.

Wani nau'in cerebrolysin bai dace da yara ba, don haka ban taɓa tsara musu wannan ba. Wasu masu haƙuri suna jure rashin jin daɗi (musamman mutane masu shekaru da kuma maza na tsaka-tsayi), don haka yawanci na ba da umarnin cerebrolysin a cikin jijiya.

Andrei Ivanovich, dan shekara 39, Moscow.

Cerebrolysin yana da tasiri cikin raunin kwakwalwa. Da muhimmanci inganta yanayin jigilar marasa lafiya, gami da masu maye giya.

Actovegin ba shi da tasiri. Amma a cikin manyan maganganu, na rubuto kawai cerebrolysin.

Petr Maksimovich, dan shekara 50, Moscow.

A cikin haɗari, mai haƙuri ya sami rauni na kai. Sama da mako guda yana cikin rashin lafiya, murmurewa daga baya wanda yayi alƙawarin zai ja ragamar rayuwa har abada. Ya tsara cerebrolysin (a cikin jijiya), haɓakawa da maido da ayyukan jikin, ya fara bayyana da sauri fiye da yadda nake tsammani. Mai haƙuri ya maimaita hanya na cerebrolysin bayan fitarwa, a gida, intramuscularly. Sakamakon ya wuce duk tsammanin.

Dmitry Igorevich, dan shekara 49, Chelyabinsk.

Actovegin ba zai iya maye gurbin cerebrolysin ba. Abokai na wani lokacin suna ba da magunguna biyu, amma na guji irin wannan "fadada" na tasirin warkewar cutar. Cerebrolysin ya wadatar da kansa.

Maxim Gennadevich, dan shekara 55, Stavropol.

Marasa lafiya a liyafar sun kawo cikakkiyar kunshin magunguna kuma sun bayyana cewa, a kan shawarar dangi da abokai, ta dauki komai. Wata tsohuwa ta koka da rashin jin daɗi, hayaniya a kai, tashin zuciya da ciwon kai. Bayan gwajin, ya gano matsaloli tare da tasoshin kwakwalwa.

An tsara shi Matar ta ji sakamakon bayan allura 3. A liyafar ta gaba, ta yarda cewa ta jefar da waɗancan magungunan.

Yaya suke aiki?

Bari mu ga abin da aka nuna a cikin umarnin magungunan.

Actovegin magani ne daga rukunin masu tayar da hankali. Bayanin abubuwa uku ya bayyana aikinsa:

Tasirin metabolism: haɓaka haɗarin oxygen ta sel, inganta haɓaka makamashi kuma yana sauƙaƙe jigilar glucose.

Tasirin neuroprotective: yana kare sel na jijiya daga lalacewa a cikin yanayin ischemia (isasshen wadataccen jini) da hypoxia (rashin isashshen oxygen).

Tasirin microcirculatory: yana motsa jini yana gudana a cikin kyallen takarda.

Ba a san yadda Actovegin zai shafi aikin jijiya ba. Wannan samfurin jini ne, kuma ba shi yiwuwa bin hanyar sa a cikin jiki. Ya kamata hemoderivative yakamata yayi aiki kamar haka:

yana hana apoptosis - kisan kwayar sel,

yana shafar ayyukan kappa B (NF-kB), wanda ke da alhakin ci gaban aikin mai kumburi a cikin juyayi,

yana gyara lalacewar DNA ga sel.

Umarnin don maganin yana nuna yana hanzarta gudanawar jini a cikin ƙananan jijiyoyin jini. Ana tsammanin sakamakon 30 mintuna bayan maganin ya shiga cikin jini. Ana lura da mafi girman tasirin maganin bayan 3-6 hours.

Nazarin haƙuri game da cerebrolysin da Actovegin

Lina G., Penza

An uwata mahaifina cerebrolysin don ya murmure daga bugun jini. Da farko ya kasance digo-ruwa. Ba da daɗewa ba, baba ya fara tashi ya yi tafiya, ko da yake ya gaji da sauri. Amma waɗanda suka san shi sun ce ya murmure sosai. Sannan mun fara allurar cerebrolysin intramuscularly. Raunin ƙwayar tsoka daga waɗannan allura ba ta da ƙarfi sosai. Tabbas, har yanzu muna kan murmurewa sosai, amma ba mu yanke tsammani. Likitanmu ya yaba wa cerebrolysin, kuma yana taimaka wa baba, abin lura ne.

Sergey Semenovich A., Moscow

Kwanan nan, an ba da horo na mako biyu na cerebrolysin. Na yi matukar azaba da cutar osteochondrosis na mahaifa, zafin da yasan mutane da yawa. Ya gaji da sauri, kusan ba zai iya aiki ba ko kuma karanta tare da sunkuyar da kansa. Ciwon kai kawai yayi mummunan gaske. Ban yarda in je likita ba, shan kwaya. Matata, bayan wani hari, ta shawo kanta in yi alƙawari. Likitan mu, Alevtina Sergeevna, ya wajabta wa cerebrolysin intramuscularly. Yanzu ni wani ne daban! Tasirin maganin yana da ban mamaki kawai.

Margarita Semenovna P., Ryazan

Ciwon kai ya wahala. Likita ya ba da umarnin Actovegin intramuscularly. Ta taimaka min. Na karanta yawancin bita kuma na ji tsoron shan maganin, amma likita ya ba da shawara, kuma na saurare. Aikin kwana goma ne. Ina jin sauki. Wani lokacin kai kawai yakanyi sauti kadan, amma na manta da tsananin zafin. Actovegin bai dace da wani ba, amma ina murna da cewa an bi shi.

Gennady Fedorovich M., St. Petersburg

Ni da matata tsofaffi ne, yawanci sukan juna a game da tinnitus da dizziness. Na ji rauni a kai na dogon lokaci, ana warkewa, amma wani lokacin kaina na ji ciwo sosai. Sonanmu ya sauke karatu daga makarantar kimiyya, kuma ya kawo mu cerebrolysin (don injections). Kuma ya saukar da kansa. Don haka yanzu muna matasa, muna jiran lokacin bazara don zuwa ƙasar.

Olga Ivanovna O., Pyatigorsk

Raunin ƙwaƙwalwa mai rauni ya lalata lafiyar ɗan'uwana. Makonni biyu ya kasance yana cikin kulawa mai zurfi, sannan dogon dawowarsa yana zuwa. Gyaran wurin ya faru a cibiyar lafiya. Kwararrun likitocin koyaushe suna lura da yanayin Anton. Munyi tunanin cewa bayan irin wannan rauni bazai ma iya motsawa ba, wata mu'ujiza ta tsira. Likitocin sun yanke shawarar hada Actovegin da cerebrolysin. Ya taimaka. Anton ya fara murmurewa. Bayan ɗan lokaci ya sake yin magana, to, an sake dawo da ayyukan motsi, tunani da ƙwaƙwalwa. Muna godiya ga likitocin ga dan uwan. Yanzu an sallame shi. Muna ci gaba da allura.

Alexey Petrovich H., Omsk

An umurce ni da cerebrolysin sau biyu. Bayan hanya ta farko babu cigaba. Duk abin da ya dame ni ya ragu. A banza jefa kudi. Don wani lokaci an magance shi da kwayoyi masu kama da cerebrolysin, amma ba a lura da sakamakon ba. Karo na biyu kenan da aka wajabta mini cerebrolysin watanni biyu da suka gabata, na yi jayayya, amma na yarda. Sakamakon ya zo da sauri, ban ma tsammani ba. Aka kuma dawo da ayyukan jikin da suka lalace.

Sai dai itace a karo na farko da na kawo wani karya ne cerebrolysin. Yana da kyau likitoci sun nace a kan karatun na biyu. Yanzu na zabi kantin magani a hankali, koyaushe ina sha'awar ingancin magunguna. Ina fatan gwanina ya shigo da hannu.

Anna V., Rostov

'Ya'ya mata 4 shekaru. Likita mai maganin ya ce muna da ZPR kuma mun bada shawarar daukar hanya ta cerebrolysin. Amma likita na gida bai wajabta mana wannan magani ba, saboda bai dace da ƙananan yara ba. Da farko na ji haushi, sannan na karanta tattaunawar, kuma na yarda da likita. Ba na son cutar da diya ta sosai.

Idan kun sami kuskure, da fatan za selecti yanki na rubutu kuma latsa Ctrl + Shigar.

Me masana kimiyyar magunguna ke faɗi?

Nazarin asibiti game da kwayoyi da ake tambaya ba a haɗa su ba. Munyi nazarin bayanai akan Actovegin da Cerebrolysin kuma mun gano cewa ba a tabbatar da tasirin magungunan ba. Babu wani tabbataccen bayani da cewa waɗannan kudade suna taimakawa wajen yaƙar bugun jini, ƙwaƙwalwar ƙwayar cuta da sauran cututtukan cututtukan zuciya. Babban gwajin da aka yi wa bazuwar yana ba da shawarar Cerebrolysin da Actovegin ba su jimre wa aikin ba. Yanzu za mu faɗi yadda muka yanke wannan shawarar.

Actovegin ya bayyana a kan kasuwar magunguna sama da shekaru 40 da suka gabata - tun kafin zamanin shahararrun magunguna. An yi amfani da shi sosai a cikin ƙwaƙwalwar ƙwayar cuta, tiyata da na mahaifin mahaifa kuma ya kafa kanta a matsayin wata hanyar da za ta maido da kwararar jini cikin kyallen. Sun kula da marasa lafiya da amai da gudawa, waɗanda ake amfani da su a cikin mata masu juna biyu da hypoxia fetal na baya. Za su ci gaba da yin amfani da shi yanzu, amma ya juya - ƙwayar ba ta biyan buƙatun zamani. Bai ƙaddamar da gwaje-gwaje na asibiti ba, kuma an gano shi a matsayin kayan aiki tare da ingantaccen tasiri.

Abubuwa Game da Actovegin:

FDA ba ta yarda da su ba - babu wata hujja mai gamsarwa cewa miyagun ƙwayoyi suna inganta kwararar jini a cikin tasoshin tare da mellitus mai rikitarwa (sake dubawa daga mujallar Diabetes Obesity & Metabolism).

Rashin inganci don rikicewar zubar jini bayan rauni (sake dubawa daga Jaridar Burtaniya ta Medicine Sports Medicine).

An lura da ingantacciyar sakamako game da maganin a wasu kafofin (jaridar "Ingantaccen Magunguna"), amma ba za mu iya amincewa da waɗannan bayanan ba. Yawancin gwaje-gwaje ba su cika ka'idojin kasa da kasa - ba a gudanar da binciken-makafi biyu ba, bazuwar, ba a sarrafa binciken placebo.

Tun daga 2017, An shawarar Actovegin don amfani kawai a cikin aikin jijiyoyi. Wani babban bincike da aka yi ya ɓata ya nuna cewa maganin yana magance yadda ya kamata tare da rikice-rikice na gudanawar ƙwayar cuta. An gabatar da jujjuyawar fassarar ne a cikin mujallar Stungiyar Bugun jini ta Rasha.

Yaushe ake nada su?

Dangane da umarnin, an wajabta Actovegin a cikin hadaddun hanyoyin magance irin waɗannan cututtukan:

take hakkin tazarar jini jini,

A cikin lokacin mummunan, ana sanya magani a cikin jijiya don kwanaki 5-7. Lokacin da tsari yayi ƙasa, an tura mai haƙuri zuwa ga kwamfutar hannu. Hanyar aikin jiyya yana gudana daga makonni 4-6 zuwa watanni shida.

Hakanan ana wajabta Cerebrolysin don maganin bugun zuciya da ƙonewar ciki. Umarnin zuwa ga miyagun ƙwayoyi yana ƙara wasu alamun:

sakamakon raunin kwakwalwa

jinkirta tunani a cikin yara.

Ana gudanar da maganin ne a cikin jijiyoyin jiki. Aikin maganin shine kwanaki 10-20.

Yaya ake ɗaukar su?

Ba a gano mummunan sakamako masu amfani da amfani da Actovegin ba. A cikin halayen da ba a san su ba, yana haifar da ci gaba na rashin lafiyan ciki - redness na fata, bayyanar rashes.

A baya ga shan Cerebrolysin, ana yawan gano tasirin sakamako:

zawo ko maƙarƙashiya

Cerebrolysin yafi amfani dashi a cikin tsofaffi marasa lafiya, kuma irin wannan halayen na iya haifar da wasu yanayi - cututtukan zuciya na zuciya, kodan, narkewa, da sauransu

Actovegin da Cerebrolysin sune kwayoyi tare da tasiri marasa amfani. Dukansu dai ba za a iya ɗauka amintattun wakilai a yaƙi da cututtukan cututtukan zuciya da na jijiyoyin jini ba.

Actovegin ya tabbatar da kansa a cikin maganin bugun jini na ischemic. Yau wannan yanki ne kawai na aikace-aikace inda magani yake aiki da gaske (gwargwadon sakamakon binciken asibiti). Game da cerebrolysin, babu irin wannan bayanan. Ba za mu iya samar da wani yanki ba inda za a iya amfani da shi daga matsayin magani na tushen shaida.

Actovegin ya dace don amfani. Ana samunsa a cikin allunan kuma ana iya amfani dashi a cikin dogon saƙo - har zuwa watanni shida. Cerebrolysin an gabatar dashi kawai a cikin hanyar mafita don allura. Ba a yi masa izini ba fiye da kwanaki 20 a jere.

Actovegin ya fi dacewa da haƙuri kuma kusan ba ya haifar da mummunan sakamako.

Lokacin zabar magani, ɗauki lokacinku tare da shawarar. Yi shawara da ƙwararren likita - likita zai gaya muku wanne magani ya dace a cikin yanayinku. Ka tuna cewa aikin Actovegin da Cerebrolysin bai yi binciken cikakke ba, kuma amfani da waɗannan magungunan ba koyaushe bane barata.

Siffar Magunguna

Lokacin yanke shawara game da alƙawarin maganin warkewa, likitan ya dogara ne da tasiri na tsarin kulawa da ake buƙata a cikin wani yanayi.

Ana ba da shawarar maganin don warkewa cikin cututtukan cuta na kwakwalwa, cututtukan jijiyoyin bugun jini, bugun jini. A cikin hanyoyin zuwa ga miyagun ƙwayoyi, an lura da kyawawan alamun kulawa don cututtukan fata na venous da na jijiya (trophic ulcer, angiopathy). Actovegin yana haɓaka sabbin ƙwayar nama (ƙonewa, rauni mai rauni, tsoka).

Yaushe haramun ne a sha maganin?

• huhun ciki.
• rashin lafiya
• bugun kirji (buguwa).
• oliguria.
• riƙewar ruwa.

An lura da alƙawarin kulawa a hypernatremia, hyperchloremia. Cutar ciki da lokacin lactation ba contraindications don yin amfani da miyagun ƙwayoyi ba, duk da haka, ana aiwatar da ilimin a karkashin kulawa sosai na likita.

Wannan magani ne na Austriya, ana gudanar dashi ta hanyar intraarterially, intramuscularly, intravenously (yadawa). Kafin gabatarwar miyagun ƙwayoyi, ana gwada maganin anaphylactic. An tsara hanya da sashi ta kwararru, bisa ga hoton asibiti. Tasirin maganin yana faruwa ne saboda ingantaccen samarda jini (glucose, oxygen).Godiya ga ingantaccen wurare dabam dabam na jini, ana kunna metabolism na salula, tare da haɓaka kayan makamashi na sel da suka ji rauni. Ma'aji 3 years.

Misalin kai tsaye na Actovegin shine Solcoseryl. Yana da nau'ikan kayan magani iri ɗaya, a ƙari, samfurin yana da farashi mai araha, amma sabanin Actovegin, yana da contraindications.

Solcoseryl ba za a iya ɗauka a cikin ƙuruciya da balaga ba (a ƙarƙashin shekaru 17), an haramta shi ga mata masu juna biyu da lokacin ciyarwa. An ba da shawarar don ƙonewa, bugun jini, ciwon sukari, a cikin ilimin hakora. Aungiyar ta Jamus-Switzerland ce ke kera magunguna. Solcoseryl ya ƙunshi abubuwan kiyayewa wanda ke haɓaka rayuwar sel, duk da haka, suna da sakamako masu illa akan ƙwayoyin hanta. Ana samun irin wannan magungunan magani a cikin magani na Mexidol.

Babban kusanci da Actovegin shine Cerebrolysin. An tabbatar da daidaituwar magungunan Cerebrolysin da Actovegin. Wadannan magungunan sun tabbatar da inganci a cikin hadaddun magani.

Yin amfani da miyagun ƙwayoyi yana da contraindications:

• an haramta hanzarta gudanar da maganin (zazzabi, tashin hankali na zuciya, rauni tare da tsananin wuya)
• mummunan aiki na gastrointestinal fili (tashin zuciya, asarar abinci, sako-sako da katako)
• a cikin lokuta mafi wuya, mummunan sakamako akan tsarin mai juyayi yana yiwuwa (tashin hankali, barcin mara kyau, ruɗewar hankali)

Wani lokacin marasa lafiya suna koka da tashin hankali na jijiya, hauhawar jini, tawayar ko rashin kyawun yanayin. Wadannan alamu ba za a iya yin watsi da su ba; ana bukatar dakatar da sarrafa magunguna na wucin gadi da kuma shawarwari na kwararru. Tare da rashin haƙuri zuwa ga abubuwanda ke ciki na Cerebrolysin, cututtukan ciki, gazawar koda, ƙwaƙwalwar ƙwaƙwalwa ta hana. A lokacin daukar ciki, an wajabta maganin a hankali.

Zai yuwu a sha magunguna tare da wasu magunguna, kuma dole ne a kula da bayanan furotin na miyagun ƙwayoyi da hoton asibiti na cutar.

Kwatanta Cerebrolysin da Actovegin

Dangane da sake dubawa game da maganin warkewar cututtukan kwakwalwa daban-daban, zamu iya yanke shawara:

• don ƙwaƙwalwar ajiya, ya fi kyau ɗaukar Cerebrolysin.
• tare da neurological, ischemic pathologies, duka magunguna suna da tasiri iri ɗaya.
• duk magungunan biyu suna jimre wa cutar ischemic, jinkirin haɓakawa, gajiya.
• Waɗannan magungunan nootropic ne.
• magunguna suna da daidai abun da ke ciki.
• don samun ingantaccen tasiri, gwani na iya tsara Actovegin da Cerebrolysin, wannan yana nuna jituwa da kwayoyi a cikin hadaddun jiyya.

Duk da bambance-bambancen alamomi, da kuma amfani da magunguna duka biyu, an hana kai kai na tsarin kulawa da magani. Hakanan ba zai yiwu ba tare da shawarar kwararrun don canza magani ɗaya zuwa wani.

Kwatantawa da magungunan guda biyu sun nuna cewa Actovegin ba shi da maganin rikice-rikice da sakamako masu illa yayin Cerebrolysin yana da adadinsu.

Actovegin ba shi da ƙuntatawa na shekaru; an wajabta shi ga yara tun farkon haihuwar sa. An wajabta magungunan yara a magungunan ƙwaƙwalwa sakamakon ƙwaƙwalwar ƙwayar cibiyar, tsawon rayuwar aikin haihuwa. Yawanci, an sanya allurar rigakafin ga ɗan, wannan shine saboda mafi kyawun tasiri na tsari. Sashin likita yana ƙayyade sashi gwargwadon nauyi da shekaru jariri. Za'a iya maye gurbin miyagun ƙwayoyi ta wani analog ɗin sa, misali Cerebrolysin, amma masanin kwararru ne kawai ya yanke wannan shawarar.

Sau da yawa, uwaye suna damuwa, suna tunanin ko zai yuwu a ɗauka Actovegin da Cerebrolysin a lokaci guda. An yarda da amfani da haɗin gwiwa, kodayake, ya kamata ka sani cewa haɗu da magunguna biyu a cikin sirinji an haramta . Wata hanyar da aka yarda da ita ita ce gabatarwar magani ɗaya a cikin allura, da kuma wani, idan babu ƙuntatawa na tsufa a cikin allunan. A wasu halaye, ana ba da magunguna kowace rana, daya bayan lokaci. Af, wannan nau'in tsarin kulawa shine mafi yawan gama gari, amma ana yarda dashi kawai don zaɓin zaɓin magani ko shawarwarin prophylactic ga ƙwararrun ko halartar likita wanda ake lura da haƙuri. Bayan haka zai iya yiwuwa a guji tasirin sakamako, yawan shan ruwa kuma kada a hada magunguna da sauran magunguna.

Vidal: https://www.vidal.ru/drugs/actovegin__35582
Radar: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGu>

An sami kuskure? Zaɓi shi kuma latsa Ctrl + Shigar

Halayyar Actovegin

Magunguna tare da bakan aiki na aiki. Magungunan suna da sakamako na neurotropic, metabolic da microcirculatory. Sakamakon shine haɓaka metabolism na makamashi, daidaita tsari na narkewar glucose ta ƙwayoyin mucous. Actovegin yana inganta hawan jini a cikin ƙananan jijiyoyin jini, yana rage sautin tsokoki na jijiyoyin jiki.

Alamu don amfani:

• far da na nakasassu da kuma cututtukan kwakwalwar da aka samo daga kwakwalwar asali daban daban,
• cutar waƙa
• azaman wakili mai raunin jiki bayan bugun jini,
• take hakkin ma'adini da kuma kewaye wurare,
• polyneuropathy ya tsokani da cuta kamar su ciwon sukari.

Siffofin saki - Allunan da kuma maganin allura. Abunda yake aiki shine mai hana haihuwa, wanda aka karɓa daga jinin wasu 'yan maruƙa da basu wuce watanni 12 da haihuwa ba.

• mutum haƙuri da aka gyara zuwa ga miyagun ƙwayoyi,
• decompensated zuciya gazawar,
• huhun ciki.

An haramta allurar rigakafin magungunan ga marasa lafiya da ke cikin cututtukan fata da kuma oliguria. An yarda da amfani da Actovegin yayin daukar ciki, amma idan kyakkyawan sakamako daga amfani da shi ya wuce hadarin matsaloli.

Sashi na likita ya wajabta:

1. Cututtukan jijiyoyin bugun kwakwalwa: 10 ml na kwanaki 14, sannan daga 5 zuwa 10 ml. Aikin likita yana da kusan wata 1.
2. Ciwon maraƙin na troulic troral: guda 10 ml da 5ram a ciki. Ana ba da allura a kowace rana. Aikin jiyya har tsawon murmurewa.
3. Nau'in cututtukan ciwon sukari na polyneuropathy: a farkon jiyya, sashi na 50 ml ne a cikin mako uku. A nan gaba, ana tura mai haƙuri zuwa nau'in kwamfutar hannu na maganin - daga allunan 2 zuwa 3 sau 3 a rana. Tsawan lokacin jiyya shine watanni 4 ko fiye.

Actovegin yana yarda da kyau ta jiki, da alama yiwuwar haɓaka bayyanar cututtuka ba ta da yawa.

Jiki ya yarda da lafiyar ta, da yiwuwar samun bayyanar cututtuka a gefe. Sakamakon sakamako masu illa sune halayen rashin lafiyan fata, ciwon kai. Ba a cire raunin narkewa ba - tashin zuciya da amai, amai, tsarin juyayi na tsakiya - ƙishi, rawar jiki daga ƙarshen, da wuya ta gaji.

Halin Cerebrolysin

Babban abin da ke cikin miyagun ƙwayoyi shine haɗuwa da cerebrolysin (wani nau'in nau'in peptide) wanda aka samo daga kwakwalwar alade. Fitar saki - bayani mai injection. Shan miyagun ƙwayoyi yana ba da gudummawa ga ingantaccen wurare dabam dabam na jini a cikin kwakwalwa ta hanyar ƙarfafa ayyukan ƙwayoyin jijiyoyi, kunna hanyoyin dawo da kariya a matakin salula.

Cerebrolysin yana rage yiwuwar infarction na myocardial, yana hana samuwar edema na ƙwaƙwalwar kwakwalwa, yana daidaita wurare dabam dabam na jini a cikin ƙananan jijiyoyin jini - capillaries. Idan mai haƙuri yana da cutar Alzheimer, ƙwayar ta sauƙaƙa yanayin kuma ta inganta ingancin rayuwa. Alamu don amfani:

1. Paarancin aiki na kwakwalwa, yana da halayya da yanayin rayuwa.
2. Cututtuka na nau'in neurodegenerative.
3. A matsayin magani ga shanyewar jiki, raunin kwakwalwa mai rauni.

Contraindications wa yin amfani da Cerebrolysin:

• mutum haƙuri da mutum aka gyara na miyagun ƙwayoyi,
• koda dysfunction
• fargaba.

Cerebrolysin yana da izinin ɗauka yayin daukar ciki kawai idan akwai takamaiman nuni game da wannan, idan kwararren ya yanke hukunci cewa kyakkyawan sakamako daga amfani da shi zai wuce haɗarin rikitarwa.

1. Pathologies na kwakwalwar kwayoyin halitta da asalin rayuwa - daga 5 zuwa 30 ml.
2. Sake dawowa bayan bugun jini - daga 10 zuwa 50 ml.
3. Raunin kwakwalwar - daga 10 zuwa 50 ml.
4. Jiyya na ƙwaƙwalwar ƙwaƙwalwa a cikin yara - daga 1 zuwa 2 ml.

Daidaitaccen jadawalin yin amfani da likita zai iya ba da izini kawai.

Ga yara daga watanni 6, an zaɓi sashi gwargwadon shirin: 0.1 ml na miyagun ƙwayoyi a kowace kilo na nauyin jiki. Matsakaicin sashi a rana shine 2 ml.

Cerebrolysin yana haifar da rikicewar tsarin narkewa - tashin zuciya da amai, jin zafi a ciki.

Sakamakon sakamako masu illa: jin sanyi da zazzabi, rage yawan ci, tashin zuciya, amai da rawar jiki, haɓakar jijiyoyin jini. Rashin narkewa na yiwuwa - tashin zuciya da amai, jin zafi a ciki.

Kwatanta Actovegin da Cerebrolysin

Magungunan suna da halaye masu yawa iri daya, amma akwai bambance-bambance.

Suna cikin rukuni ɗaya na magungunan magani (magungunan da ke shafar metabolism na nama). Magungunan suna da manufa iri ɗaya na aikin da aka inganta inganta ƙwaƙwalwar ƙwayar ƙwaƙwalwa, farfadowa, ƙarfafawa da kariya daga tasoshin kai. Magunguna suna da guda hanyoyin da suke tasiri kan jikin ɗan adam:

• suna da tasiri mai tasiri a cikin kwakwalwa,
• yi tasirin magani
• dakatar da bayyanar da rauni gaba daya da rashin hankali,
• nuna tasiri iri ɗaya a cikin tasirin antidepressant,
• suna da maganin cututtukan gabbai,
• da tasiri kan ayyukan cortex cortex, tabbatar da maido da aikin magana bayan bugun jini, inganta hankali da tunani,
• tare da guda tasiri suna da tasirin mnemotropic - suna inganta ƙwaƙwalwar ajiya, haɓaka matsayin ilimi,
• kayan adaptogenic - kariyar sel da kwakwalwa da jijiyoyin jini daga mummunan tasirin abubuwan cutarwa na yanayin waje da na ciki.

Dukansu magunguna suna ba da gudummawa ga daidaituwa game da wurare dabam dabam na jini, kawar da tsutsa da sauran alamomi waɗanda ke haɗuwa da cututtukan jijiyoyin jini a cikin kwakwalwa. Ana iya amfani dasu azaman prophylaxis bayan bugun jini don saurin dawo da kwantar da hankali da tunani.

Menene bambanci?

1. Haɗin magungunan ya bambanta, saboda abubuwa masu aiki - na asali daban-daban.
2. Fom ɗin saki. Actovegin yana samuwa a cikin allunan kuma a matsayin mafita don allura, Cerebrolysin - kawai a cikin hanyar maganin allura.
3. Actovegin ba shi da ƙuntatawa na shekaru don ƙaddamarwa: ana iya amfani dashi a cikin lura da raunin jijiyoyin jiki a cikin yara daga farkon lokacin rayuwa idan akwai alamomi irin su hypoxia m, wuyan wuyan tare da igiyar tsumma, raunin da aka ci yayin haihuwa.
4. An dauke Actovegin a matsayin magani mafi aminci, saboda yana da ƙarami da kuma alama na alamun bayyanar cututtuka.
5. Mai kera: Cerebrolysin ne ya samar da kamfanin sarrafa magunguna na Austriya, magani na biyu yana a cikin Jamus.

Wanne ya fi kyau - Actovegin ko Cerebrolysin?

Nessarfin magungunan na iya bambanta, gwargwadon yanayin asibiti da kuma alamun amfani. Idan akwai buƙatar haɓaka aikin kwakwalwa, ƙwaƙwalwa da taro, ana ba da fifiko ga Cerebrolysin.

A cikin lura da cutar ischemic, ƙarancin aiki a cikin aikin kwakwalwa na nau'in ƙwaƙwalwar ƙwaƙwalwa, duka magunguna suna nuna tasiri ɗaya. Magunguna za su iya jurewa tare da sakamakon bugun zuciya, jinkirta tunanin yara a cikin yara, da kuma nakasassu a cikin tsofaffi marassa lafiya.

Don haɓaka tasirin warkewa da cimma sakamako mai ɗorewa, an yarda da rikice-rikice tare da magunguna biyu. Amma haɗaka magunguna a cikin sirinji iri ɗaya an haramta shi sosai. Ana gudanar da magunguna a madadinsu.

Mafi kyawun zaɓi don haɗakar amfani da kwayoyi shine haɗuwa da nau'i na Cerebrolysin da nau'i na Actovegin.

Shin zai yiwu a sauya magani ɗaya tare da wani?

Ana iya maye gurbin Actovegin ta Cerebrolysin da mataimakin, idan ɗayan magungunan suna haifar da alamun gefen, ko kuma na dogon lokaci babu wani sakamako mai kyau daga amfani da shi. An yanke shawarar maye gurbin maganin ne kawai daga likitan, kuma ya zaɓi matakin da ya dace.

Alaƙa da bambance-bambance na Cerebrolysin da Actovegin

Alaƙa tsakanin magungunan ita ce, an tsara Actovegin da Cerebrolysin don bugun jini, raunin intracranial, don haɓaka ayyukan kwakwalwa, da dai sauransu Alamar don amfani shine ciwon kai. Shan waɗannan magunguna ba jaraba bane, baya da sakamako masu illa (babu mummunar illa ga jikin ɗan adam). Duk magungunan biyu na iya shiga cikin yara da manya.

Bambanci tsakanin magungunan shine Cerebrolysin yana da ƙarin sakamako masu illa da contraindications (tare da iv gudanarwa) fiye da Actovegin (wannan magani ba shi da kusan babu, rashin lafiyan yana yiwuwa).

Wanne ya fi kyau - Actovegin ko Cerebrolysin

Actovegin da Cerebrolysin ana amfani da su a cikin neurology, don cututtukan da ke da alaƙa da rikicewar jijiyoyin jiki, raunin intracranial, da sauransu. Amsar tambayar wanene mafi kyau - Actovegin ko Cerebrolysin, ya dogara ne akan takamaiman yanayin da ra'ayin likitan halartar wanda ya san duk tarihin cutar. Likita ne kawai ke da 'yancin tsara magunguna, gami da kayyade adadin magungunan ga mai haƙuri, tsawon lokacin magani, da dai sauransu.

Ba daidai ba ne a kwatanta waɗannan magunguna: ana amfani dasu sosai kuma suna tasiri a cikin magance manyan cututtuka. Sau da yawa, don haɓaka mafi girma, ana rubanya magungunan biyu a cikin hanya guda ta hanyoyin kwantar da hankali.